花生过敏治疗市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按药物类别、给药途径、分销渠道、地区和竞争细分

全球花生过敏治疗市场预计在 2024-2028 年预测期内将出现令人印象深刻的增长。这种增长是由于人们对花生过敏的认识不断提高和技术进步所致。

提高对花生过敏的认识

花生过敏日益流行正在推动全球花生过敏治疗市场的增长。花生过敏已成为一个重大的公共卫生问题，影响着全世界数百万人，并且病例数量持续上升。

因此，对花生过敏的有效治疗方法的需求不断增加。这导致了各种可以帮助管理和治疗花生过敏的产品和疗法的开发，例如花生过敏免疫疗法、口服免疫疗法和舌下免疫疗法。

该市场包括花生过敏疫苗、口服免疫治疗药物、舌下免疫治疗药物等多种产品。

製药公司和政府组织加大对研发活动的投资，开发花生过敏的有效治疗方法，推动了市场的发展。此外，随着公众对花生过敏的认识不断提高，预计未来几年对花生过敏治疗的需求将增加。

人们对花生过敏的认识不断增强

对花生过敏的日益了解正在影响全球花生过敏治疗市场的增长。随着医学研究的进步，人们对花生过敏的原因和机制有了更深入的了解，这导致了新的、更有效的治疗方法的开发。

例如，研究人员现在正在探索新的免疫治疗方法，可以提供更持久的花生过敏保护。此外，正在开发新的诊断工具，可以帮助医生更准确地诊断和管理花生过敏。

随着对花生过敏的了解不断加深，可能会刺激对新的创新治疗方法的需求。随着越来越多的人意识到与花生过敏相关的严重健康风险及其对生活质量的影响，这一点尤其如此。

此外，人们对花生过敏的认识不断提高，导致更多的资金被用于研究和开发花生过敏的新疗法。这反过来又推动了全球花生过敏治疗市场的增长，因为公司正在开发新产品和疗法来满足患者的需求。

对花生过敏的了解不断加深，对全球花生过敏治疗市场的增长产生了重大影响。

增加研发投资

增加研发投资是全球花生过敏治疗市场增长的主要推动力。随着花生过敏患病率持续上升，对更有效治疗方法的需求不断增长，这导致对研发活动的投资增加。

製药公司、政府组织和研究机构正在大力投资开发针对花生过敏的创新疗法。例如，正在研究新型免疫疗法，包括口服和舌下免疫疗法，以及新型花生过敏疫苗的开发。

这些投资还推动了更准确、更高效的花生过敏诊断工具的开发，这将帮助医生更有效地诊断和管理病情。

此外，对研发活动的投资不断增加，导致花生过敏治疗的新方法和创新方法的发现。这包括现有药物的新配方，以及这些药物的新递送机制。

可用的定制：

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

• 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场细分

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要行业合作伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量和验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球花生过敏治疗市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按药物类别（抗组胺药、肾上腺素、免疫疗法、其他）
  • 按给药途径（口服、静脉注射、其他）
  • 按分销渠道（零售药房、医院药房、网上药房）
  • 按地区
  • 按公司划分 (2022)
• 产品图
  • 按药物类别
  • 按给药途径
  • 按分销渠道
  • 按地区

第 6 章：北美花生过敏治疗市场前景

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按药物类别
  • 按给药途径
  • 按分销渠道
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲花生过敏治疗市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按药物类别
  • 按给药途径
  • 按分销渠道
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第 8 章：亚太地区花生过敏治疗市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按药物类别
  • 按给药途径
  • 按分销渠道
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第 9 章：南美花生过敏治疗市场前景

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按药物类别
  • 按给药途径
  • 按分销渠道
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲花生过敏治疗市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按药物类别
  • 按给药途径
  • 按分销渠道
  • 按国家/地区
• MEA：国家分析
  • 南非花生过敏治疗
  • 沙特阿拉伯花生过敏治疗
  • 阿联酋花生过敏治疗

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球花生过敏治疗市场：SWOT 分析

第 14 章：波特的五力分析

• 行业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 产品供应
• 最近的发展
• 主要人员
• SWOT分析
  • Vedanta Biosciences, Inc.
  • Alladapt Immunotherapeutics, Inc.
  • Regeneron Pharmaceuticals Inc.
  • Aravax Pty Ltd
  • Teva Pharmaceutical Industries Limited
  • Prota Therapeutics Pty Ltd.
  • Aimmune Therapeutics, Inc. (Nestle)
  • DBV Technologies SA
  • Sanofi SA

第 16 章：战略建议

Global Peanut Allergy Treatment Market is expected to see impressive growth during the forecast period 2024-2028. This growth is accounted for by the increasing awareness of peanut allergy and advances in technology.

Peanut allergy is a serious and potentially life-threatening condition affecting millions of people worldwide. The Peanut Allergy Treatment Market has been growing rapidly in recent years due to the increasing prevalence of peanut allergy and the need for effective treatment options.

Advances in research have led to a better understanding of the mechanisms underlying peanut allergy, which has enabled the development of more targeted and effective treatments.

For example, the development of allergen-specific immunotherapy and gene therapies would not have been possible without advances in biotechnology and genetic engineering.

Many pharmaceutical companies and research institutions have recognized the potential of the peanut allergy treatment market and are investing heavily in developing new treatments through research and development.

Additionally, the regulatory environment is another factor driving the growth of peanut allergy treatments. Regulatory agencies such as the FDA and the European Medicines Agency (EMA) have recently issued guidelines aimed at improving the safety and efficacy of peanut allergy treatments. These guidelines have provided greater clarity for companies developing new treatments and have helped to drive innovation in the Peanut Allergy Treatment Market.

Immunotherapy, epinephrine auto-injectors, food labeling regulations, alternative foods, and gene therapy are trends that are shaping the future of peanut allergy treatment.

Immunotherapy is a treatment that aims to desensitize the patient's immune system to the allergen, in this case, peanuts. It involves introducing the allergen to the patient in gradually increasing doses over a period of several months or years, allowing the body to build up a tolerance to the allergen. Immunotherapy is a prominent form of treatment that reduces the severity of allergic reactions to peanuts.

Gene therapy is an effective treatment option that involves altering the genes responsible for producing the allergic response to peanuts. This therapy aims to eliminate the allergic response altogether, providing a potential cure for peanut allergies. While gene therapy is still in the experimental stage, it shows great promise for the future of peanut allergy treatment.

The growth of Global Peanut Allergy Treatment Market is hampered by various challenges. These challenges include the risk of severe allergic reactions, limited access to treatment, the cost of treatment, limited effectiveness, and a lack of understanding of the condition.

The last three years have seen several significant product launches related to peanut allergy treatment, providing new options for those who suffer from this condition. These products are helping to transform the peanut allergy treatment market, providing patients with new options for managing their condition and improving their quality of life. In 2020, Aimmune Therapeutics launched Palforzia, the first FDA-approved treatment for peanut allergy. Palforzia is an oral immunotherapy drug that gradually desensitizes patients to peanuts, reducing their risk of having an allergic reaction. This treatment has the potential to be life-changing for those with peanut allergy, providing a new option for managing their condition.

In 2019, DBV Technologies launched Viaskin Peanut, a peanut allergy treatment that uses a patch to deliver small amounts of peanut allergen through the skin. The treatment is designed to gradually desensitize patients to peanuts and reduce the risk of allergic reactions. Viaskin Peanut has been shown to be effective in clinical trials and has received FDA fast-track designation.

In 2019, Johnson & Johnson announced plans to launch a peanut allergy patch that delivers small amounts of peanut allergen through the skin. The patch is designed to gradually desensitize patients to peanuts and reduce the risk of allergic reactions. The peanut allergy patch is currently undergoing clinical trials and has the potential to be a game-changer in the peanut allergy treatment market.

ARA-101 is an oral immunotherapy drug developed by Aimmune Therapeutics that desensitizes patients to peanuts. ARA-101 is currently undergoing clinical trials and has shown promising results in reducing the risk of allergic reactions to peanuts. If approved, ARA-101 could be a valuable addition to the peanut allergy treatment market.

Increasing Awareness of Peanut Allergy

The increasing prevalence of peanut allergy is driving the growth of the Global Peanut Allergy Treatment Market. Peanut allergies have become a significant public health concern, affecting millions of people worldwide, and the number of cases continues to rise.

As a result, there is an increasing demand for effective treatments for peanut allergies. This has led to the development of various products and therapies that can help manage and treat peanut allergies, such as peanut allergy immunotherapy, oral immunotherapy, and sublingual immunotherapy.

The market includes various products such as peanut allergy vaccines, oral immunotherapy drugs, sublingual immunotherapy drugs, and others.

The market is being driven by increased investments in research and development activities by pharmaceutical companies and government organizations to develop effective treatments for peanut allergies. Additionally, the increasing awareness about peanut allergies among the general population is expected to boost the demand for peanut allergy treatments in the coming years.

Growing Awareness Regarding the Peanut Allergy

The growing understanding of peanut allergy is influencing the growth of the Global Peanut Allergy Treatment Market. With advances in medical research, there is a greater understanding of the causes and mechanisms of peanut allergy, which is leading to the development of new and more effective treatments.

For example, researchers are now exploring new approaches to immunotherapy that could provide longer-lasting protection against peanut allergies. Additionally, new diagnostic tools are being developed that can help physicians more accurately diagnose and manage peanut allergies.

As the understanding of peanut allergies continues to grow, it is likely to fuel demand for new and innovative treatments. This is particularly true as more people become aware of the serious health risks associated with peanut allergies and the impact they can have on quality of life.

Furthermore, the increasing awareness of peanut allergies has led to more funding being directed towards research and development of new treatments for peanut allergies. This, in turn, is driving the growth of the Global Peanut Allergy Treatment Market as companies are developing new products and therapies to meet the needs of patients.

The growing understanding of peanut allergies has a significant impact on the growth of the Global Peanut Allergy Treatment Market.

Increasing Investment in Research & Development

Increasing investment in research and development is a major driver of the growth of the Global Peanut Allergy Treatment Market. As the prevalence of peanut allergy continues to rise, there is a growing need for more effective treatments, which has led to increased investment in research and development activities.

Pharmaceutical companies, government organizations, and research institutions are investing heavily in developing new and innovative treatments for peanut allergy. For example, there is ongoing research into new types of immunotherapies, including oral and sublingual immunotherapy, as well as the development of new peanut allergy vaccines.

These investments are also driving the development of more accurate and efficient diagnostic tools for peanut allergies, which will help physicians to diagnose and manage the condition more effectively.

Moreover, the increasing investment in research and development activities has led to the discovery of new and innovative methods for peanut allergy treatment. This includes novel formulations of existing drugs, as well as new delivery mechanisms for these drugs.

Market Segmentation

Global Peanut Allergy Treatment Market can be segmented by drug class, route of administration, distribution channel, and sand region. Based on drug class, the market can be divided into antihistamines, epinephrine, immunotherapies, and others. Based on the route of administration, the market is divided into oral, intravenous, and others. Based on distribution channels, the market is divided into retail pharmacies, hospital pharmacies, and online pharmacies. Regionally, the Peanut Allergy Treatment Market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Vedanta Biosciences, Inc., Alladapt Immunotherapeutics, Inc., Regeneron Pharmaceuticals Inc., Aravax Pty Ltd, Teva Pharmaceutical Industries Limited, Prota Therapeutics Pty Ltd., Aimmune Therapeutics, Inc. (Nestle), DBV Technologies SA, Sanofi SA are some of the leading players operating in the Global Peanut Allergy Treatment Market.

Report Scope:

In this report, Global Peanut Allergy Treatment Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Global Peanut Allergy Treatment Market, By Drug Class:

• Antihistamines
• Epinephrine
• Immunotherapies
• Others

Global Peanut Allergy Treatment Market, By Route of Administration:

• Oral
• Intravenous
• Others

Global Peanut Allergy Treatment Market, By Distribution Channel:

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Peanut Allergy Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Peanut Allergy Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Drug Class (Antihistamines, Epinephrine, Immunotherapies, Others)
  • 5.2.2. By Route of Administration (Oral, Intravenous, Others)
  • 5.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Product Map
  • 5.3.1. By Drug Class
  • 5.3.2. By Route of Administration
  • 5.3.3. By Distribution Channel
  • 5.3.4. By Region

6. North America Peanut Allergy Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Drug Class
  • 6.2.2. By Route of Administration
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Peanut Allergy Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Drug Class
      • 6.3.1.2.2. By Route of Administration
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Peanut Allergy Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Drug Class
      • 6.3.2.2.2. By Route of Administration
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Peanut Allergy Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Drug Class
      • 6.3.3.2.2. By Route of Administration
      • 6.3.3.2.3. By Distribution Channel

7. Europe Peanut Allergy Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drug Class
  • 7.2.2. By Route of Administration
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Peanut Allergy Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Drug Class
      • 7.3.1.2.2. By Route of Administration
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. Germany Peanut Allergy Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Drug Class
      • 7.3.2.2.2. By Route of Administration
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Peanut Allergy Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Drug Class
      • 7.3.3.2.2. By Route of Administration
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Peanut Allergy Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Drug Class
      • 7.3.4.2.2. By Route of Administration
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Peanut Allergy Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Drug Class
      • 7.3.5.2.2. By Route of Administration
      • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Peanut Allergy Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Drug Class
  • 8.2.2. By Route of Administration
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Peanut Allergy Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Drug Class
      • 8.3.1.2.2. By Route of Administration
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Peanut Allergy Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Drug Class
      • 8.3.2.2.2. By Route of Administration
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Peanut Allergy Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Drug Class
      • 8.3.3.2.2. By Route of Administration
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Peanut Allergy Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Drug Class
      • 8.3.4.2.2. By Route of Administration
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Peanut Allergy Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Drug Class
      • 8.3.5.2.2. By Route of Administration
      • 8.3.5.2.3. By Distribution Channel

9. South America Peanut Allergy Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Drug Class
  • 9.2.2. By Route of Administration
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Peanut Allergy Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Drug Class
      • 9.3.1.2.2. By Route of Administration
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Argentina Peanut Allergy Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Drug Class
      • 9.3.2.2.2. By Route of Administration
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. Colombia Peanut Allergy Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Drug Class
      • 9.3.3.2.2. By Route of Administration
      • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Peanut Allergy Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Drug Class
  • 10.2.2. By Route of Administration
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Peanut Allergy Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Drug Class
      • 10.3.1.2.2. By Route of Administration
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Saudi Arabia Peanut Allergy Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Drug Class
      • 10.3.2.2.2. By Route of Administration
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. UAE Peanut Allergy Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Drug Class
      • 10.3.3.2.2. By Route of Administration
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Peanut Allergy Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. Vedanta Biosciences, Inc.
  • 15.5.2. Alladapt Immunotherapeutics, Inc.
  • 15.5.3. Regeneron Pharmaceuticals Inc.
  • 15.5.4. Aravax Pty Ltd
  • 15.5.5. Teva Pharmaceutical Industries Limited
  • 15.5.6. Prota Therapeutics Pty Ltd.
  • 15.5.7. Aimmune Therapeutics, Inc. (Nestle)
  • 15.5.8. DBV Technologies SA
  • 15.5.9. Sanofi SA

16. Strategic Recommendations